Vitiligo is an autoimmune condition which results in the loss of melanocytes and consequent depigmentation of the skin. It is thought to affect around 1% of the population and symptoms typically develop by the age of 20\-30 years.  
  
Associated conditions  
* type 1 diabetes mellitus
* Addison's disease
* autoimmune thyroid disorders
* pernicious anaemia
* alopecia areata

  
Features  
* well\-demarcated patches of depigmented skin
* the peripheries tend to be most affected
* trauma may precipitate new lesions (Koebner phenomenon)

  
[![](https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd029.jpg)](https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd029b.jpg)[![](https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd960.jpg)](https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd960b.jpg)[![](https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd030.jpg)](https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd030b.jpg)[![](https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd031.jpg)](https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd031b.jpg)  
Management  
* sunblock for affected areas of skin
* camouflage make\-up
* topical corticosteroids may reverse the changes if applied early
* there may also be a role for topical tacrolimus and phototherapy, although caution needs to be exercised with light\-skinned patients
